Worldwide Protein Expression Market (2019 to 2028) - Featuring Genscript, Lifesensors & Qiagen Among Others - ResearchAndMarkets.com

The "Global Protein Expression Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.

According to an analysis by the publisher, the global protein expression market is expected to grow at a CAGR of 11.30% during the forecasting period 2019-2028.

The growing prevalence of chronic diseases across the globe is primarily driving the demand for the protein expression market. This is due to the increasing use of protein expression in therapeutic applications. Besides, the increasing health expenditure and the growing research & development activities in the fields of genomics are also favoring the market growth.

Also, the rising pharmaceutical market is likely to create immense opportunities for protein expression systems. However, the high cost of expression systems and reactants are restraining the market growth. Strict regulatory approvals also hinder the global protein expression market development. The lack of high yield systems for post-translation modifications is also posing a challenge to the global market growth.

The global market report covers the countries from North America, Europe, the Asia-Pacific, Latin America and the Middle East and Africa.

Asia-Pacific will be the fastest-growing region for the protein expression market in the coming years. The growing awareness regarding the benefits of the protein expression and their use in therapeutics. Due to the improving health standards of the countries in this region and the rising applications of this system, Asia-Pacific is anticipated to create immense growth opportunities for the studied market. Also, as the disposable income of the people has increased, consumers are now able to afford these treatments and are more aware of the early detection of diseases. Moreover, the region is home to several key players of the market, thereby favoring the regional market growth.

Market Dynamics

Drivers

• Growing Prevalence of Chronic Diseases
• Rise in Healthcare Expenditure
• Increasing R&D in the Fields of Genomics and Proteomics

Restraints

• High Cost of Protein Expression Systems
• Stringent Regulatory Approval

Opportunities

• Rise in Pharmaceutical Market in Emerging Regions

Challenges

• Lack of Effective Systems for Post-Translational Modifications

Companies Mentioned

• Agilent Technologies Inc
• BD (Becton, Dickinson and Company)
• Bio-Rad Laboratories Inc
• Genscript
• Lifesensors
• Merck Kgaa
• Promega Corporation
• Qiagen
• Takara Holdings Inc
• Thermo Fisher Scientific Inc
• Lonza
• New England Biolabs
• Biotechrabbit
• Promab
• Peak Proteins Ltd

For more information about this report visit https://www.researchandmarkets.com/r/hc9pf4

View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005519/en/